Lindholm, Evita Maria; Kristian, Alexandr; Nalwoga, Hawa; Kruger, Kristi; Nygård, Ståle; Akslen, Lars A.; Mælandsmo, Gunhild (Journal article; Tidsskriftartikkel; Peer reviewed, 2012-03-31)
Several clinical trials have investigated the efficacy of bevacizumab in breast cancer, and
even if growth inhibiting effects have been registered when antiangiogenic treatment is
given in combination with chemotherapy no gain in overall survival has been observed.
One reason for the lack of overall survival benefit might be that appropriate criteria for selection of patients likely to respond ...